Clinical Trials Directory

Trials / Completed

CompletedNCT00684697

Iron Status and Myelination in Premature Infants

Double Blind Randomized Placebo Controlled Trial of Iron Supplementation in Premature Infants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
University of Rochester · Academic / Other
Sex
All
Age
32 Weeks
Healthy volunteers
Not accepted

Summary

Premature infants with iron deficiency if supplemented with more elemental iron than the routine 2mg/kg/day will have improved brain development.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTironHigh, intermediate and low iron dosage orally for 2 months

Timeline

Start date
2009-05-01
Primary completion
2015-12-31
Completion
2020-12-31
First posted
2008-05-28
Last updated
2021-03-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00684697. Inclusion in this directory is not an endorsement.

Iron Status and Myelination in Premature Infants (NCT00684697) · Clinical Trials Directory